Our findings establish a pathway of immune-metabolic crosstalk between F4/80+ KCs and hepatocytes that drive the metabolic reprogramming of hepatocytes, which includes the dampening of harmful effects of fructose metabolism as well as lipogenic metabolism during the transition of steatosis to steatohepatitis. The gene discussed is TBCE; the disease is steatosis.